Rachel L Spreng Selected Research

Biomarkers (Surrogate Marker)

1/2021

Comprehensive Data Integration Approach to Assess Immune Responses and Correlates of RTS,S/AS01-Mediated Protection From Malaria Infection in Controlled Human Malaria Infection Trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rachel L Spreng Research Topics

Disease

7	Infections 01/2023 - 01/2019
2	Malaria 08/2021 - 01/2021
2	Typhoid Fever (Typhoid) 01/2021 - 01/2019
1	Human Influenza (Influenza) 05/2024
1	Parasitemia 01/2021

Drug/Important Bio-Agent (IBA)

6	VaccinesIBA 01/2023 - 01/2019
2	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 08/2021 - 01/2021
2	Immunoglobulin G (IgG)IBA 01/2021 - 01/2019
1	Hemagglutinins (Hemagglutinin)IBA 05/2024
1	AntibodiesIBA 08/2021
1	Proteins (Proteins, Gene)FDA Link 08/2021
1	Malaria VaccinesIBA 08/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	EpitopesIBA 01/2021
1	Adenosine Diphosphate (ADP)IBA 01/2021
1	Conjugate VaccinesIBA 01/2021
1	Fc Receptors (Fc Receptor)IBA 01/2021
1	Broadly Neutralizing AntibodiesIBA 01/2021
1	Immunoglobulin A (IgA)IBA 01/2019
1	Polysaccharides (Glycans)IBA 01/2019
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2019
1	AntigensIBA 01/2019